In-Silico Study of Bone Cancer Activity of N-Benzylideneaniline
DOI:
https://doi.org/10.63682/jns.v14i32S.9124Keywords:
N-Benzylideneaniline, bonecancer, Swiss ADME, AutodockingAbstract
This study aims to describe the bone cancer activity of N-Benzylideneaniline , In this compound was predicted potential drug in medicinal field confirmed by swiss ADME software. Further, analaysed the bone cancer activity of N-Benzylideneaniline by Autodocking study and find out the binding energy compound. in this study was confirmed is very potential bone cancer drug. So, In future, N-Benzylideneaniline may be very effective bone cancer drug in the soceity and medicinal field.
Downloads
Metrics
References
Shaoyi Cai a c, Gengzheng Zhu a c, Xiaohong Cen a c, Jingjie Bi a, Jingru Zhang a, Xiaoshan Tang a, Kun Chen b, Kui Cheng Synthesis, structure-activity relationships and preliminary mechanism study of N-benzylideneaniline derivatives as potential TLR2 inhibitors, Bioorganic & Medicinal Chemistry,26, 8, 2041-2050(2018), https://doi.org/10.1016/j.bmc.2018.03.001
2. Yusuf Özkay, Zerrin İncesu, İlhan Işıkdağ, Mehmet Yeşilkaya ,Antiproliferative effects of some N-benzylideneanilines, CELL BIOCHEMISTRY AND FUNCTIONS, 6 (2007),https://doi.org/10.1002/cbf.1406
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
